- Nilotinib, sold
under the
brand name
Tasigna marketed worldwide by Novartis, is a
medication used to
treat chronic myelogenous leukemia (CML)
which has...
- Disease".
Archived from the
original on 30 July 2013. "NICE
Backs Novartis's
Tasigna For CML,
Rejects BMS's Sprycel", The Wall
Street Journal, online.wsj.com...
- (Nexavar)
Sunitinib (Sutent)
Dasatinib (Sprycel)
Lapatinib (Tykerb)
Nilotinib (
Tasigna)
Bortezomib (Velcade) is an apoptosis-inducing
proteasome inhibitor drug...
- "
Tasigna : EPAR -
Product Information" (PDF).
European Medicines Agency.
Novartis Europharm Ltd. 18
October 2013.
Retrieved 25
January 2014. "
Tasigna 150mg...
- (Sprycel) Abl, Arg, KIT, PDGFR, Src Imatinib-resistant CML 2007
Nilotinib (
Tasigna) Abl, Arg, KIT,
PDGFR Imatinib-resistant CML 2007
Lapatinib (Tykerb) EGFR...
